13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neurocritical Care Specialists
Neurocritical care specialists provide advanced, life-saving treatment for patients suffering from severe neurological conditions, particularly in intensive care settings. They manage acute conditions such as traumatic brain injury, stroke, seizures, and brain hemorrhages, often working in neuro-intensive care units (ICUs). Their expertise allows them to quickly assess neurological deterioration, monitor brain function, and implement interventions to preserve brain tissue. These specialists use sophisticated tools like intracranial pressure monitors, cerebral oxygenation measurement, and continuous EEG to closely monitor patients in critical states. The goal is to stabilize the patient, prevent secondary brain injury, and ensure recovery or rehabilitation after the acute phase. In the long-term care of these patients, neurocritical care specialists oversee rehabilitation strategies, including physical therapy, speech therapy, and neuropsychological support. They often collaborate with other medical teams such as neurosurgeons and neurologists to optimize treatment protocols. Their work includes the development of advanced monitoring techniques and participation in clinical trials, aiming to improve outcomes in critical care. Neurocritical care specialists play an essential role in managing complex, high-risk patients, ensuring that they receive comprehensive, holistic care throughout their recovery.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States